The dialysate concentration of large proteins increases, on average, linearly during the whole peritoneal dialysis dwell, and this linear pattern seems to be independent of the rate of ultrafiltration induced by dialysis fluid. However, we observed a high variability of protein kinetics in individual dwell studies. Therefore, we studied the details of the kinetic pattern of peritoneal transport. ♦ ♦ ♦ ♦ ♦ Design and Methods: Kinetics of β β β β β 2 -microglobulin, albumin, and total protein was examined in 23 clinically stable continuous ambulatory peritoneal dialysis patients using 
P rotein loss during peritoneal dialysis (PD) has been a concern since the beginning of chronic clinical applications of this therapy . A common observation is that the increase of protein (and other macromolecules) concentration in dialysate during peritoneal dwell studies is usually linear with dwell time (4, 14, 22) . This pattern has been reported for dwell studies using different glucose concentrations (Dianeal 1.36%, 2.27%, and 3.86% in PD patients, and lactated Ringer's solution and 15% dextrose solution in rats), which induced different ultrafiltration (UF) rates (4, 14, 22) . Therefore, one might expect that protein transport is independent of fluid UF from blood to dialysate. Theoretically, UF may result in faster increase of solute concentration in dialysate if the concentration of the solute in ultrafiltrate is higher than in dialysate -this is often the case at the beginning of a peritoneal dwell. Otherwise, if solute concentration in ultrafiltrate is lower than in dialysate, then UF may induce a dilution of the solution and a decrease in the equilibration rate or even in the solute concentration in dialysate itself.
High sieving effect (i.e., low sieving coefficient) for protein during PD (i.e., faster transport of water than of protein) should have a dilutional impact on protein concentration in dialysate, especially if the UF 4 0 WANIEWSKI et al.
JANUARY 2000 -VOL. 20, NO. 1 PDI rate is high. In fact, the concentration of protein in the dialysate is considerably lower in dwell studies with strongly hypertonic (glucose 3.86%, with high initial UF) than with less hypertonic (glucose 1.36%, with low initial UF) dialysis solutions (4, 6, 22) . However, the protein amount in dialysate and protein clearance did not differ between these two solutions (6, 22, 23) . The same effect was also observed in peritoneal transport studies in rats with strongly hypertonic solution (dextrose 15%) compared to isotonic lactated Ringer's solution (14) . Despite a very regular linear (on average) increase in protein concentration in dialysate, interindividual scattering in transport patterns and transport parameters for protein is high, and typically much higher in studies with strong hypertonic than with less hypertonic dialysis solutions. This observation may suggest that, in addition to the general impact of net UF on protein concentration in dialysate (but not on the amount removed or the final clearance of protein during the dwell), high UF has a discriminative impact on protein transport in patients studied using hypertonic dialysis fluids. The objective of the present study was to investigate in detail the time course and the main interindividual differences in peritoneal protein transport among continuous ambulatory peritoneal dialysis (CAPD) patients, as well as to describe the role of UF in peritoneal protein loss.
M E T H O D S

CLINICAL PROTOCOL
Six-hour dwell studies with 2 L of Dianeal 3.86% (D3.86%, n = 15) and Dianeal 1.36% (D1.36%, n = 9) were carried out in 23 clinically stable CAPD patients without any sign of UF capacity loss. In 1 patient, two dwell studies were performed: one with each dialysis fluid.
Briefly, radioisotopically labeled albumin (RISA) was added to the dialysis fluid as a volume marker. To minimize binding of RISA to plastic material, 0.2 g of human serum albumin was added to the bag. Dialysate samples were taken from a three-way stopcock halfway through infusion and at 3, 15, 30, 60, 90, 120, 180, 240, and 360 minutes after complete infusion of dialysis fluid, and blood samples at 0, 180, and 360 minutes after complete infusion of dialysis fluid. A sample was also collected from the overnight dialysis fluid, which was drained just before the dwell study. The patients were instructed to sit up or to move about in bed before each sampling of the dialysate; otherwise they were recumbent through the 6-hour investigation. Prior to each sampling, 10 mL of dialysate was flushed back and forth five times through the stopcock (24) . CONCENTRATION 
MEASUREMENTS
Blood and dialysate samples were analyzed for RISA activity on an Intertechnique CG Gamma Counter (Intertechnique, Plaisir, France). Albumin was analyzed using an immunoturbidometric method, β 2 -microglobulin (B2M) by the Phadebas RIA method (Pharmacia, Uppsala, Sweden), and total protein with an IL 919 system (Instrumentation Laboratory, Milan, Italy). The lower limits of detection of the assays used to measure protein concentration in dialysate were 4 mg/L for albumin, 50 μg/L for B2M, and 0.1 g/L for total protein. Concentrations of small solutes (urea, creatinine, glucose, sodium, potassium) were measured as described previously (24) .
DETERMINATION OF DIALYSATE VOLUME AND SOLUTE TRANSPORT PARAMETERS Intraperitoneal dialysate volumes (V D ) were estimated from the dilution of RISA with corrections applied for the elimination of RISA from the peritoneal cavity [coefficient of marker elimination, (K E )] and sample volumes, as described previously (24) . The solute transport parameters [diffusive mass transport coefficient (K BD )] and sieving coefficient (S) were estimated using the generalized version of the BabbRanderson-Farrell model (BRF model) as described previously (22) . The BRF model assumes that the rate of net change of the solute mass in dialysate results from three transport components: (1) diffusive transport between blood and dialysate, (2) convective transport from blood, and (3) bulk absorption of fluid from the peritoneal cavity (25) . The computer program Pertran (Baxter Novum) was used for the evaluation of peritoneal dwell studies, and can be found at http://www.ibib.waw.pl/~peritome. Clearance of solutes at time t of the dwell was calculated as the difference in solute mass in dialysate at time t and at 3 minutes after the instillation of the fluid, divided by the time of the dwell (t -3), and normalized to the solute concentration in plasma.
The data are presented as mean ± standard deviation, if not stated otherwise. Results were evaluated using Student's t-test, if not stated otherwise.
R E S U L T S
The concentration of albumin in dialysate during dwell studies with D3.86% dialysis fluid increased, on average, almost linearly, with an only slightly higher rate at the beginning of the dwell study (Figure 1) . However, the change of albumin concentration in dialysate with dwell time varied substantially between individual patients, especially during the initial part of the dwell study (3 -30 min). To quantify this variability, we compared the slope of the regression line for the initial 3 -30 min (three sampling points) versus the slope of the regression line for 60 -360 min (six sampling points). The ratio of these two slopes (SR) was higher than 1 if the initial rate of increase of albumin concentration in dialysate was higher than the rate of increase during the remaining dwell time, and lower than 1 if the initial rate of change was lower than the later rate of change. In fact, we found SR to be lower than 1 in 5 patients; these patients were considered low albumin transporters (LAT group, median SR = 0.49, range -4.39 -0.71). In 2 of these patients, albumin concentration decreased during the initial 30 min of the dwell study. The rest of the patients (n = 10) were considered high albumin transporters (HAT group, median SR = 2.77, range 1.32 -7.56). The kinetic patterns for albumin concentration in dialysate for the two albumin transport groups are shown in Figure 1 . The division of the patients into two groups was exactly the same had it been done based on albumin dialysate-toplasma concentration ratio (D/P) instead of only albumin concentration in dialysate, because plasma concentration of albumin was almost constant throughout the dwell study in the CAPD patients.
The transport of proteins smaller than albumin did not differ between the LAT and HAT groups, as assessed for B2M ( Figure 1 ). Nevertheless, the transport pattern for albumin substantially affected concentration changes of total protein in dialysate ( Figure 1 ). The ratio of the initial over the later slopes (SR) of linear regression lines for albumin correlated to SR for B2M (r = 0.636, p < 0.05) and for total protein (r = 0.707, p < 0.005). The SR for total protein correlated highly to SR for B2M (r = 0.942, p < 0.001). The concentration of total protein in plasma tended to be lower in the HAT group than in the LAT group (65.1 ± 6.2 g/L vs 71.6 ± 5.4 g/L, respectively; p < 0.07), and the concentration of total protein in the overnight dialysis fluid (drained before the dwell study) was higher in the HAT group than in the LAT group (1.5 g/L vs 1.1 g/L, respectively; p < 0.05). The concentration of albumin in the overnight fluid also tended to be higher in the HAT group than in the LAT group (0.53 g/L vs 0.46 g/L, respectively; p = 0.07).
No statistically significant difference between K BD values for albumin, B2M, and total protein between the HAT and LAT groups was found (Table 1 ). In contrast, S values for albumin and total protein in the LAT group were lower than in the HAT group (Table 1) . The S values for sodium correlated with S values for albumin (r = 0.615, p < 0.05) and for total protein (r = 0.528, p < 0.05). No differences between the HAT and LAT groups in dialysate volume, volume marker absorption rate (K E ), and the transport coefficients, K BD and S, for small solutes were found.
Similar transport patterns were observed in dwell studies with D1.36% dialysis fluid. In 3 patients, the SR values for albumin were lower than 1 (LAT group, median SR = 0.95, range 0.70 -0.97), and in 6 patients they were higher than 1 (HAT group, median SR = 1.55, range 1.23 -1.98). The concentration versus dwell-time curves for albumin, total protein, and B2M are shown in Figure 2 . Sieving coefficient for albumin was significantly lower in the LAT group than in the HAT group using D1.36% dialysis fluid, but other transport parameters for proteins did not differ between these two groups ( Table 2) . No differ- ences in plasma protein concentrations, dialysate volume, marker absorption rate (K E ), and the transport parameters, K BD and S, for small solutes were found between the two groups.
The gap in the average concentration between the LAT and the HAT group for albumin and total protein was smaller for dwell studies using D1.36% than those using D3.86% (e.g., 0.10 g/L vs 0.14 g/L for albumin concentrations at 30 min). Furthermore, the SR value for the LAT group was higher with D1.36% than with D3.86% dialysis fluids (p < 0.05, median test); for the HAT group the SR value was lower with D1.36% than with D3.86% (p < 0.05, median test).
The concentrations of proteins in dialysate were substantially lower in dwell studies with D3.86% than with D1.36% dialysis fluid (Figures 1 and 2 ), due to higher dialysate volumes with the former fluid and the dilution effect. However, no difference in protein mass in dialysate was found for total protein and B2M. In contrast, the mass of albumin in dialysate was lower with D3.86% than with D1.36% dialysis fluids after 4 hours of the exchange (1.2 g vs 1.6 g at 360 min, respectively; p < 0.05).
As a result of these differences in the mass of albumin in dialysate, the values of albumin clearances at 360 min were lower with D3.86% than with D1.36% (0.062 mL/min vs 0.088 mL/min, respectively; p < 0.05); however, no significant difference was found before 240 min of the dwell (Figures 3 and 4) . The clearances of total protein and B2M were not different between the two dialysis fluids for any period of the dwell.
The clearances of albumin, on the other hand, were significantly lower during the initial part of the dwell in the LAT group than in the HAT group using D3.86% fluid (Figure 3) , and the clearances of total protein also tended to be lower during this period (Figure 3) . However, no statistically significant difference was found in clearances of B2M with D3.86% fluid (nor were there any differences between clearances of the three proteins with D1.36% fluid) between the LAT and HAT groups (Figures 3 and 4) .
DISCUSSION
The high UF rate induced by hypertonic glucose solution has a double impact on the protein transport pattern: (1) In general, UF decreases protein concentration in dialysate (due to dilution) but does not change the total amount of protein lost in dialysate during a 6-hour dwell, compared to dwells with low UF rate. This effect, caused by generally high sieving of proteins with ultrafiltrate flow, was found in the present as well as in a few previous studies (4, 6, 14, 22, 23) . (2) In addition, UF may substantially increase the transport of large proteins in some patients during the initial part of peritoneal dwell, whereas in others it may have the opposite effect and decrease the net rate of protein transport, as shown in the present study. This discriminative effect of UF should be more pronounced in dwells with strongly hypertonic dialysis fluids. The major findings of our study are as follows: (1) The kinetic patterns of albumin transport were not linear for the whole dwell time. Net transport of The separation into two transport groups (HAT and LAT groups) was done on the basis of the above three observations. Therefore, the problem described in the present paper is not only about statistical variability of transport patterns: some physiological explanation should be sought.
We should first discuss the possibility that the difference in kinetic patterns of albumin concentration in dialysate might be due to the difference in the amount of albumin in the residual fluid -which remained in the peritoneal cavity after the drainage of overnight dialysate before the dwell study, and mixed slowly with the infused fresh dialysis fluid. The volume of the residual fluid before the dwell study was not measured in our investigations. In general, there is no simple and reliable method to do such measurements. Thus we may provide only indirect arguments against the possible explanation of our finding by the difference in albumin amount in the residual fluid. First of all, we did not find any difference between the HAT and LAT groups in dialysate volume at 3 minutes, or at any later time during the dwell. Next, the concentration of albumin in the residual fluid (approximately 0.5 g/L) was higher than in the infused fluid (0.1 g/L), and any mixing of these two fluids should have resulted in an increased concentration of albumin in dialysate, which was, however, not observed during the initial 30 min in the LAT group. Furthermore, the difference in albumin transport between the HAT and LAT groups was much higher in dwell studies with glucose 3.86% than with glucose 1.36%. If the difference was due to the amount of albumin in the residual fluid we would expect it to be independent of the dialysis fluid used for the dwell study.
Finally, let us assume that the transport rate of albumin was similar in the HAT and LAT groups also during the initial 30 min of the dwell studies, and attribute the difference between the groups to the difference in the amount of albumin in the residual fluid. The mixing of the residual and the infused fluids might be delayed, so that only at 30 min was equilibrium reached. With these assumptions, the difference in the amount of albumin in the dialysate at 30 min (0.696 ± 0.200 g in the HAT group, 0.329 ± 0.091 g in the LAT group; p < 0.001) should be due only to the difference in the amount of albumin in the residual fluid. The albumin concentration in the residual fluid was similar in both groups (0.53 g/L in the HAT group, 0.46 g/L in the LAT group), so we may assume that, on average, the concentration was 0.5 g/L for both groups. Therefore, the difference in the amount of albumin in the dialysate at 30 min (0.367 g) must have arisen owing to the difference of 0.734 L in the volume of residual fluid. Such a high difference between the groups of 10 (HAT group) and 5 (LAT group) patients is rather improbable. In fact, the residual volumes after the dwell studies were 0.676 ± 0.671 L in the HAT group and 0.402 ± 0.189 L in the LAT group; the difference was not statistically significant.
Based on the above arguments, we do not think it likely that the difference in albumin transport between the HAT and LAT groups can be explained by a difference in the amount of albumin in the residual fluid. Thus, another factor must be responsible for the observed patterns of albumin kinetics.
In fact, the initial pattern of changes in albumin concentration was clearly influenced by the convective component of solute transport. The contribution of convective transport to net solute transport depends on the UF rate and the solute concentration in ultrafiltrate, which in turn is dependent on the solute concentration in plasma and the value of the solute sieving coefficient (S). This description of convective solute transport was applied in the BRF model, which was used in the current study for modeling of protein transport in PD. However, the model may not take into account all details of the transport process, in spite of the correct formal description of the observed transport kinetics. In particular, albumin that is transported into the peritoneal cavity comes only in part from blood. The rest of the amount of albumin in dialysate comes from the interstitial space of the tissues surrounding the peritoneal cavity. This observation has been documented in several studies on the transport of labeled (RISA) and native albumin from blood to dialysate (2, 3, 26) . Labeled albumin appeared in dialysate with some delay, and the amount transported to the dialysate was lower than that of native albumin (2, 3, 26) . Furthermore, saturation of tissue with labeled albumin infused into blood takes over 12 hours (27) . The differences in clearances of intravenously administered dextrans and native proteins of similar EinsteinStokes radius were interpreted as representative of delayed transport of dextrans due to the impact of the "interstitial compartment" between blood and dialysate (18) . Thus, the transport of plasma albumin PDI JANUARY 2000 -VOL. 20, NO. 1 PERITONEAL TRANSPORT OF PROTEINS from blood to tissue, and further to the dialysate, is a rather slow process. Therefore, one may expect that albumin appearing in dialysate during the initial phase of PD (e.g., during the initial 30 min) comes mainly from the interstitium. The transport of interstitial albumin seems to be much modified by UF from blood. Ultrafiltration flow is induced by high glucose concentration and passes through ultrasmall and small pores in the capillary wall, which are rather impenetrable for albumin. Thus the albumin-depleted water flow from blood capillaries may have washed out albumin from the interstitium. The final concentration of albumin in the flow entering the peritoneal cavity depends on the pathways for that flow within the interstitium and through the mesothelium.
As seen in our study, in many CAPD patients (HAT group, about two thirds of the patients) UF seems to be the cause of the fast increase of albumin concentration in dialysate, at least faster than the increase of albumin concentration during the later dwell phase without substantial UF. In these patients, the water flow is enriched with albumin, probably due to the passage through a pathway that is not restrictive for albumin. However, in some patients (LAT group, about one third of the patients) albumin transport during the initial phase of the dwell is slower than that during the later phase of the dwell, in spite of rates of UF similar to the HAT group. In these patients, water flow is depleted of albumin and probably travels via the interstitial and transmesothelial pathways, which are restrictive for albumin. The correlation of SR values for albumin and B2M suggests that these pathways for convective transport share similar characteristics for these two proteins, although the effect of UF on B2M transport is less pronounced than for larger proteins.
The initially higher protein transport resembles similar time-dependent transport of small solutes with higher initial rate (25, 28) . It has been suggested that diffusive mass transport coefficients (K BD ) for small solutes are higher during the initial 120 min than during the later phase of the dwell due to increased perfusion of the tissue, which is induced by vasodilatory factors in dialysis fluid (25, 28) , and does not depend on the tonicity of the fluid (25, 28) . In contrast to the mainly diffusive transport of small solutes, the initial clearances for the studied proteins are slightly increased during the initial period (less than 1 hour), and are higher with D3.86% than with D1.36% in HAT groups.
The observation that, in some patients, transport of proteins may be retarded during the initial phase with high UF rate is puzzling and needs further studies. However, because the difference in the transport patterns arises early during the dwell study (i.e., at 30 min) the LAT group of patients may have a relatively lower loss of large proteins also in automated PD.
In summary, this study confirms that the rate of protein transport, on average and during the later part of the dwell, is constant, and therefore the concentration-versus-time curve is essentially linear. However, a close examination of changes in protein transport during the initial 30 -60 min reveals that UF may indeed affect initial protein transport, although this impact may vary considerably between patients. As reflected by differences in sieving coefficient for albumin, the initial ultrafiltrate flow seems to be either enriched with or depleted of albumin, and therefore the differences may be masked by statistical averaging. The underlying mechanisms are not known.
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